Blog
RSS FeedPosted by Michael Wonder on 28 Sep 2019
AveXis rules out EU compassionate use of SMA gene therapy, says Biogen option is available
27 September 2019 - Novartis’ AveXis unit has given its reasons for refusing to supply its spinal muscular atrophy gene ...
Posted by Michael Wonder on 27 Sep 2019
Industry shoots down Labour's plans to tackle 'extortionate' drug prices
26 September 2019 - Labour's promise to “take on pharmaceutical companies” which “deny life-saving and life-changing medicines to ill patients ...
Posted by Michael Wonder on 27 Sep 2019
With Brexit looming, what does the future hold for UK biosimilars?
26 September 2019 - If and when the United Kingdom leaves the European Union, the Medicines and Healthcare Products Regulatory Agency ...
Posted by Michael Wonder on 26 Sep 2019
Migraine drug not cost effective NICE says in final draft guidance
26 September 2019 - NICE has said that a new drug for preventing migraine is not a cost effective use of ...
Posted by Michael Wonder on 25 Sep 2019
NICE terminates another three assessments
25 September 2019 - NICE has terminated 11 assessments so far this year. ...
Posted by Michael Wonder on 25 Sep 2019
Labour Party takes aim at pharma, calls attention to Orkambi row
25 September 2019 - Proposal to introduce compulsory licensing faces industry criticism. ...
Posted by Michael Wonder on 25 Sep 2019
Children with cancer are missing out on precision medicine, study finds
24 September 2019 - Only a small number of children with solid tumour cancers are able to access targeted precision ...
Posted by Michael Wonder on 24 Sep 2019
Government announces 'no deal' protection for UK nationals in EU
24 September 2019 - The government has announced 'no deal' contingency plans designed to protect healthcare access for UK nationals ...
Posted by Michael Wonder on 24 Sep 2019
Drug firms admit to colluding in order to keep prices up
20 September 2019 - Two suppliers of the antidepressant, nortriptyline, have admitted illegally sharing information in order to keep prices up. ...
Posted by Michael Wonder on 23 Sep 2019
NICE numbers at 20 – a closer look at cancer
23 September 2019 - There has been continual interest in what the UK’s health technology assessment agency, NICE, has said ...
Posted by Michael Wonder on 23 Sep 2019
UK families in buyers club fly to Argentina for cystic fibrosis drugs
23 September 2019 - Six British people have travelled to Argentina to get supplies of two potentially life-saving medicines for ...
Posted by Michael Wonder on 23 Sep 2019
Labour will abolish prescription fees for everyone in England, party to announce
21 September 2019 - Jeremy Corbyn will pledge to abolish charges for all medicine prescribed by NHS doctors, as he ...
Posted by Michael Wonder on 23 Sep 2019
NICE seeks feedback from users of the evidence standards framework for digital health technologies
23 September 2019 - Consultation on priority areas open to stakeholders until mid October. ...
Posted by Michael Wonder on 18 Sep 2019
NICE recommends Takhzyro
18 September 2019 - NICE - a health technology appraisal body in England and Wales - has recommended the use ...
Posted by Michael Wonder on 18 Sep 2019
'A child's health should not be a postcode lottery': anger of cystic fibrosis sufferers forced to pay £20,000 for drug abroad
17 September 2019 - Patients have formed a buyers' club to source a version of Orkambi after the drug's manufacturer and ...